ADPT
Price
$10.57
Change
+$0.19 (+1.83%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
1.58B
37 days until earnings call
CSLLY
Price
$77.85
Change
-$1.14 (-1.44%)
Updated
Jun 20 closing price
Capitalization
75.4B
Interact to see
Advertisement

ADPT vs CSLLY

Header iconADPT vs CSLLY Comparison
Open Charts ADPT vs CSLLYBanner chart's image
Adaptive Biotechnologies
Price$10.57
Change+$0.19 (+1.83%)
Volume$15.78K
Capitalization1.58B
CSL
Price$77.85
Change-$1.14 (-1.44%)
Volume$124.09K
Capitalization75.4B
ADPT vs CSLLY Comparison Chart in %
Loading...
ADPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CSLLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADPT vs. CSLLY commentary
Jun 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADPT is a StrongBuy and CSLLY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2025
Stock price -- (ADPT: $10.56 vs. CSLLY: $78.39)
Brand notoriety: ADPT: Notable vs. CSLLY: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADPT: 70% vs. CSLLY: 129%
Market capitalization -- ADPT: $1.58B vs. CSLLY: $75.4B
ADPT [@Biotechnology] is valued at $1.58B. CSLLY’s [@Biotechnology] market capitalization is $75.4B. The market cap for tickers in the [@Biotechnology] industry ranges from $326.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADPT’s FA Score shows that 0 FA rating(s) are green whileCSLLY’s FA Score has 1 green FA rating(s).

  • ADPT’s FA Score: 0 green, 5 red.
  • CSLLY’s FA Score: 1 green, 4 red.
According to our system of comparison, both ADPT and CSLLY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADPT’s TA Score shows that 3 TA indicator(s) are bullish while CSLLY’s TA Score has 4 bullish TA indicator(s).

  • ADPT’s TA Score: 3 bullish, 5 bearish.
  • CSLLY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CSLLY is a better buy in the short-term than ADPT.

Price Growth

ADPT (@Biotechnology) experienced а +2.62% price change this week, while CSLLY (@Biotechnology) price change was -0.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.24%. For the same industry, the average monthly price growth was +27.91%, and the average quarterly price growth was +12.28%.

Reported Earning Dates

ADPT is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (-2.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSLLY($75.4B) has a higher market cap than ADPT($1.58B). ADPT YTD gains are higher at: 76.147 vs. CSLLY (-9.734). CSLLY has higher annual earnings (EBITDA): 4.73B vs. ADPT (-111.63M). CSLLY has more cash in the bank: 1.52B vs. ADPT (193M). ADPT has less debt than CSLLY: ADPT (86.9M) vs CSLLY (12B). CSLLY has higher revenues than ADPT: CSLLY (14.7B) vs ADPT (190M).
ADPTCSLLYADPT / CSLLY
Capitalization1.58B75.4B2%
EBITDA-111.63M4.73B-2%
Gain YTD76.147-9.734-782%
P/E RatioN/A28.77-
Revenue190M14.7B1%
Total Cash193M1.52B13%
Total Debt86.9M12B1%
FUNDAMENTALS RATINGS
ADPT vs CSLLY: Fundamental Ratings
ADPT
CSLLY
OUTLOOK RATING
1..100
3650
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
2
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9753
PRICE GROWTH RATING
1..100
3675
P/E GROWTH RATING
1..100
10081
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CSLLY's Valuation (2) in the null industry is somewhat better than the same rating for ADPT (62) in the Hospital Or Nursing Management industry. This means that CSLLY’s stock grew somewhat faster than ADPT’s over the last 12 months.

CSLLY's Profit vs Risk Rating (100) in the null industry is in the same range as ADPT (100) in the Hospital Or Nursing Management industry. This means that CSLLY’s stock grew similarly to ADPT’s over the last 12 months.

CSLLY's SMR Rating (53) in the null industry is somewhat better than the same rating for ADPT (97) in the Hospital Or Nursing Management industry. This means that CSLLY’s stock grew somewhat faster than ADPT’s over the last 12 months.

ADPT's Price Growth Rating (36) in the Hospital Or Nursing Management industry is somewhat better than the same rating for CSLLY (75) in the null industry. This means that ADPT’s stock grew somewhat faster than CSLLY’s over the last 12 months.

CSLLY's P/E Growth Rating (81) in the null industry is in the same range as ADPT (100) in the Hospital Or Nursing Management industry. This means that CSLLY’s stock grew similarly to ADPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADPTCSLLY
RSI
ODDS (%)
Bearish Trend 4 days ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
53%
Momentum
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
61%
MACD
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
63%
Advances
ODDS (%)
Bullish Trend 13 days ago
81%
Bullish Trend 14 days ago
53%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 18 days ago
64%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
66%
Aroon
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 8 days ago
50%
View a ticker or compare two or three
Interact to see
Advertisement
ADPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CSLLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JHUKX33.940.10
+0.30%
JPMorgan Emerging Markets Equity R4
GBCCX14.86N/A
N/A
Gabelli Dividend Growth C
MACPX27.09N/A
N/A
BlackRock Balanced Institutional
KTRSX9.08N/A
N/A
DWS Global Income Builder S
EMFIX11.83N/A
N/A
Ashmore Emerging Markets Equity Instl

ADPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADPT has been loosely correlated with AXON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ADPT jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADPT
1D Price
Change %
ADPT100%
+1.73%
AXON - ADPT
56%
Loosely correlated
+0.76%
VCYT - ADPT
54%
Loosely correlated
+1.21%
BEAM - ADPT
50%
Loosely correlated
-0.30%
ARRY - ADPT
50%
Loosely correlated
-0.14%
TECH - ADPT
49%
Loosely correlated
-1.18%
More

CSLLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSLLY has been loosely correlated with ADPT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CSLLY jumps, then ADPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSLLY
1D Price
Change %
CSLLY100%
+0.69%
ADPT - CSLLY
34%
Loosely correlated
+1.73%
RXRX - CSLLY
34%
Loosely correlated
-3.78%
VIR - CSLLY
33%
Poorly correlated
-3.07%
FOLD - CSLLY
33%
Poorly correlated
-0.35%
CDXS - CSLLY
33%
Poorly correlated
+3.06%
More